From developing new therapies to help patients cope with anxiety to discovering new ways to treat resistant breast cancer and new environmentally friendly methods for producing chemotherapy drugs, ¶¶ÒõÂÃÐÐÉä Boulder researchers are pushing boundaries in cancer research. In recognition of National Cancer Research Month, here’s a sampling of recent projects.
Writing to wellness: New therapy helps cancer patients face biggest fears
With new medications extending the lives of advanced cancer patients, many live for years in the face of radical uncertainty. A new ¶¶ÒõÂÃÐÐÉä Boulder-born therapy has been shown to reduce trauma, depression, anxiety and fear.
How silencing a gene-silencer could lead to new cancer drugs
¶¶ÒõÂÃÐÐÉä Boulder research reveals how a molecular machine known as PRC2 helps determine which cells become heart cells, versus brain or muscle or skin cells. The findings shed light on how development occurs and could pave the way for novel cancer treatments.
Why breast cancer survivors don’t take their meds, and what can be done about it
Hormone-blocking drugs can be life-saving for breast cancer survivors, reducing risk of recurrence by as much as 50%. Yet many patients stop taking them early or don’t take them as directed. ¶¶ÒõÂÃÐÐÉä Boulder researchÌýexplores why, and what can be done about it.
When it comes to treating resistant breast cancer, 2 drugs may be better than 1
¶¶ÒõÂÃÐÐÉä Boulder research shows that cancer cells can adapt in as little as one to two hours to new drugs called CDK2 inhibitors. The good news: Adding a second, widely available drug disables this workaround, squelching tumor growth.
New ‘magic beans’ produce ingredients for cancer treatments, vaccines, more
Tens of thousands of sharks are killed each year to harvest a key ingredient for vaccines, while old growth trees are slashed to obtain chemotherapy ingredients. Soybean farmer-turned molecular biologist Brian DeDecker has a better idea.
Researchers identify promising new target for drug-resistant breast and ovarian cancers
By inhibiting a protein that helps cancer cells repair themselves, scientists hope to develop new drugs that treat resistant tumors with fewer side effects.
